Pharmacy boards move to a kinder, gentler approach of regulating for outcomes
Iowa Governor Signs Bill Limiting PBM Practices
SF 383 prohibits PBMs from limiting patient choice of pharmacy, unfairly excluding pharmacies from networks, and forces them to reimburse pharmacies no less than what they pay affiliated pharmacies for the same drug.
Pharmacy Law Lowdown: PBM Audit Trends, Enforcement Actions
Dae Lee, PharmD, Esq, CPBS and Lucas Morgan, Esq, discuss PBM and board of pharmacy enforcement actions, trends in PBM audits, and more.
Bipartisan Bill Aims to Combat PBMs’ Medicaid Spread-Pricing
US Senators on both sides of the aisle came together to announce the Protecting Pharmacies in Medicaid Act.
Podcast: Is The Pharmacy World Prepared For DSCSA?
Todd Eury of the Pharmacy Podcast Network is joined by Josh Bolin of the NABP to talk about DSCSA, what benefits it will provide, and how to make sure your pharmacy is ready when it goes into effect this November.
NCPA Joins Class Action Suit Against GoodRx, Industry-Leading PBMs
Along with discount drug card company GoodRx, the suit is aimed at CVS Caremark, Express Scripts, MedImpact Healthcare Systems, and Navitus Health Solutions.
PBMs Significantly Marked Up Specialty Generic Drugs
The Federal Trade Commission released its second interim staff report on industry-leading pharmacy benefit managers and their practices specifically regarding specialty drugs.
